{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T12:44:52Z","timestamp":1759495492964,"version":"3.37.3"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T00:00:00Z","timestamp":1722988800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T00:00:00Z","timestamp":1722988800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"DFG - GRK2543\/1","award":["#663952"],"award-info":[{"award-number":["#663952"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"DOI":"10.1007\/s00345-024-05182-z","type":"journal-article","created":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T12:04:50Z","timestamp":1723032290000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Patient-derived bladder cancer organoids show stable transcript expression along cultivation"],"prefix":"10.1007","volume":"42","author":[{"given":"Philipp","family":"Vollmer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bastian","family":"Amend","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niklas","family":"Harland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnulf","family":"Stenzl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Igor","family":"Tsaur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moritz","family":"Maas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wilhelm K.","family":"Aicher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3757-158X","authenticated-orcid":false,"given":"Simon","family":"Walz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,8,7]]},"reference":[{"issue":"8","key":"5182_CR1","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1007\/s00345-019-02984-4","volume":"38","author":"A Richters","year":"2020","unstructured":"Richters A, Aben KKH, Kiemeney LALM (2020) The global burden of urinary bladder cancer: an update. World J Urol 38(8):1895\u20131904","journal-title":"World J Urol"},{"issue":"8","key":"5182_CR2","first-page":"507","volume":"96","author":"KC DeGEORGE","year":"2017","unstructured":"DeGEORGE KC, Holt HR, Hodges SC (2017) Bladder cancer: diagnosis and treatment. Am Fam Phys 96(8):507\u2013514","journal-title":"Am Fam Phys"},{"issue":"2","key":"5182_CR3","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.eururo.2014.09.007","volume":"67","author":"H Zargar","year":"2015","unstructured":"Zargar H, Espiritu PN, Fairey AS, Mertens LS, Dinney CP, Mir MC et al (2015) Multicenter assessment of neoadjuvant chemotherapy for muscle-invasive bladder cancer. Eur Urol 67(2):241\u2013249","journal-title":"Eur Urol"},{"issue":"10","key":"5182_CR4","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1200\/JCO.2011.38.6979","volume":"30","author":"J Bellmunt","year":"2012","unstructured":"Bellmunt J, von der Maase H, Mead GM, Skoneczna I, De Santis M, Daugaard G et al (2012) Randomized phase III study comparing paclitaxel\/cisplatin\/gemcitabine and gemcitabine\/cisplatin in patients with locally advanced or metastatic urothelial cancer without prior systemic therapy: EORTC Intergroup Study 30987. J Clin Oncol 30(10):1107","journal-title":"J Clin Oncol"},{"key":"5182_CR5","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1053\/j.seminoncol.2012.08.007","volume":"39","author":"J Bellmunt","year":"2012","unstructured":"Bellmunt J, Petrylak DP (2012) New therapeutic challenges in advanced bladder cancer. Semin Oncol 39:598\u2013607","journal-title":"Semin Oncol"},{"issue":"3","key":"5182_CR6","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.eururo.2005.12.031","volume":"49","author":"RJ Sylvester","year":"2006","unstructured":"Sylvester RJ, Van Der Meijden AP, Oosterlinck W, Witjes JA, Bouffioux C, Denis L et al (2006) Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol 49(3):466\u2013477","journal-title":"Eur Urol"},{"issue":"6","key":"5182_CR7","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.acuro.2013.01.005","volume":"37","author":"J Huguet","year":"2013","unstructured":"Huguet J (2013) Follow-up after radical cystectomy based on patterns of tumor recurrence and its risk factors. Actas Urol Esp (English Edition) 37(6):376\u2013382","journal-title":"Actas Urol Esp (English Edition)"},{"issue":"2","key":"5182_CR8","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.cell.2018.03.017","volume":"173","author":"SH Lee","year":"2018","unstructured":"Lee SH, Hu W, Matulay JT, Silva MV, Owczarek TB, Kim K et al (2018) Tumor evolution and drug response in patient-derived organoid models of bladder cancer. Cell 173(2):515\u201328.e17","journal-title":"Cell"},{"issue":"10","key":"5182_CR9","doi-asserted-by":"publisher","first-page":"4567","DOI":"10.1073\/pnas.1803595116","volume":"116","author":"J Mullenders","year":"2019","unstructured":"Mullenders J, de Jongh E, Brousali A, Roosen M, Blom JPA, Begthel H et al (2019) Mouse and human urothelial cancer organoids: a tool for bladder cancer research. Proc Natl Acad Sci U S A 116(10):4567\u20134574","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5182_CR10","unstructured":"Systems R. Cultrex Basement Membrane Extract (BME) and Extracellular Matrices (ECM) 2023 [Available from: https:\/\/www.rndsystems.com\/products\/cultrex-basement-membrane-extract-bme-and-extracellular-matrices-ecm."},{"key":"5182_CR11","unstructured":"Corning (2023) Corning\u00ae Matrigel\u00ae Matrix [Available from: https:\/\/www.corning.com\/emea\/de\/products\/life-sciences\/products\/surfaces\/matrigel-matrix.html."},{"issue":"1","key":"5182_CR12","doi-asserted-by":"publisher","first-page":"C151","DOI":"10.1152\/ajpcell.00120.2020","volume":"319","author":"C Corr\u00f2","year":"2020","unstructured":"Corr\u00f2 C, Novellasdemunt L, Li VSW (2020) A brief history of organoids. Am J Physiol Cell Physiol 319(1):C151\u2013C165","journal-title":"Am J Physiol Cell Physiol"},{"issue":"11","key":"5182_CR13","doi-asserted-by":"publisher","first-page":"6305","DOI":"10.3390\/ijms23116305","volume":"23","author":"Y Wei","year":"2022","unstructured":"Wei Y, Amend B, Todenh\u00f6fer T, Lipke N, Aicher WK, Fend F et al (2022) Urinary tract tumor organoids reveal eminent differences in drug sensitivities when compared to 2-dimensional culture systems. Int J Mol Sci 23(11):6305","journal-title":"Int J Mol Sci"},{"issue":"7","key":"5182_CR14","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1016\/j.cell.2016.05.082","volume":"165","author":"H Clevers","year":"2016","unstructured":"Clevers H (2016) Modeling development and disease with organoids. Cell 165(7):1586\u20131597","journal-title":"Cell"},{"issue":"5","key":"5182_CR15","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1158\/2159-8290.CD-16-1154","volume":"7","author":"C Pauli","year":"2017","unstructured":"Pauli C, Hopkins BD, Prandi D, Shaw R, Fedrizzi T, Sboner A et al (2017) Personalized in vitro and in vivo cancer models to guide precision medicine. Cancer Discov 7(5):462\u2013477","journal-title":"Cancer Discov"},{"issue":"10","key":"5182_CR16","doi-asserted-by":"publisher","first-page":"5453","DOI":"10.3390\/ijms23105453","volume":"23","author":"R Geng","year":"2022","unstructured":"Geng R, Harland N, Montes-Mojarro IA, Fend F, Aicher WK, Stenzl A et al (2022) CD24: a marker for an extended expansion potential of urothelial cancer cell organoids in vitro? Int J Mol Sci 23(10):5453","journal-title":"Int J Mol Sci"},{"issue":"11","key":"5182_CR17","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1007\/s12094-016-1489-x","volume":"18","author":"F Kong","year":"2016","unstructured":"Kong F, Gao F, Li H, Liu H, Zhang Y, Zheng R et al (2016) CD47: a potential immunotherapy target for eliminating cancer cells. Clin Transl Oncol 18(11):1051\u20131055","journal-title":"Clin Transl Oncol"},{"issue":"9","key":"5182_CR18","doi-asserted-by":"publisher","first-page":"4969","DOI":"10.3390\/ijms23094969","volume":"23","author":"N Harland","year":"2022","unstructured":"Harland N, Maurer FB, Abruzzese T, Bock C, Montes-Mojarro IA, Fend F et al (2022) Elevated expression of the immune checkpoint ligand CD276 (B7\u2013H3) in urothelial carcinoma cell lines correlates negatively with the cell proliferation. Int J Mol Sci 23(9):4969","journal-title":"Int J Mol Sci"},{"key":"5182_CR19","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.ctrv.2017.01.007","volume":"54","author":"J Bellmunt","year":"2017","unstructured":"Bellmunt J, Powles T, Vogelzang NJ (2017) A review on the evolution of PD-1\/PD-L1 immunotherapy for bladder cancer: the future is now. Cancer Treat Rev 54:58\u201367","journal-title":"Cancer Treat Rev"},{"issue":"1","key":"5182_CR20","doi-asserted-by":"publisher","first-page":"4609","DOI":"10.1038\/s41598-021-83662-7","volume":"11","author":"EY Cai","year":"2021","unstructured":"Cai EY, Garcia J, Liu Y, Vakar-Lopez F, Arora S, Nguyen HM et al (2021) A bladder cancer patient-derived xenograft displays aggressive growth dynamics in vivo and in organoid culture. Sci Rep 11(1):4609","journal-title":"Sci Rep"},{"issue":"7839","key":"5182_CR21","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1038\/s41586-020-3034-x","volume":"588","author":"E Kim","year":"2020","unstructured":"Kim E, Choi S, Kang B, Kong J, Kim Y, Yoon WH et al (2020) Creation of bladder assembloids mimicking tissue regeneration and cancer. Nature 588(7839):664\u2013669","journal-title":"Nature"},{"issue":"7","key":"5182_CR22","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/s41568-018-0007-6","volume":"18","author":"J Drost","year":"2018","unstructured":"Drost J, Clevers H (2018) Organoids in cancer research. Nat Rev Cancer 18(7):407\u2013418","journal-title":"Nat Rev Cancer"},{"issue":"11","key":"5182_CR23","doi-asserted-by":"publisher","first-page":"2748","DOI":"10.3390\/cancers13112748","volume":"13","author":"ML Uribe","year":"2021","unstructured":"Uribe ML, Marrocco I, Yarden Y (2021) EGFR in cancer: signaling mechanisms, drugs, and acquired resistance. Cancers 13(11):2748","journal-title":"Cancers"},{"issue":"1","key":"5182_CR24","doi-asserted-by":"publisher","first-page":"2214","DOI":"10.1038\/s41467-023-37696-2","volume":"14","author":"M Minoli","year":"2023","unstructured":"Minoli M, Cantore T, Hanhart D, Kiener M, Fedrizzi T, La Manna F et al (2023) Bladder cancer organoids as a functional system to model different disease stages and therapy response. Nat Commun 14(1):2214","journal-title":"Nat Commun"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-024-05182-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00345-024-05182-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-024-05182-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T21:18:55Z","timestamp":1735852735000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00345-024-05182-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,7]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["5182"],"URL":"https:\/\/doi.org\/10.1007\/s00345-024-05182-z","relation":{},"ISSN":["1433-8726"],"issn-type":[{"type":"electronic","value":"1433-8726"}],"subject":[],"published":{"date-parts":[[2024,8,7]]},"assertion":[{"value":"20 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"468"}}